The Discounted Cash Flow (DCF) valuation of Spero Therapeutics Inc (SPRO) is 2.76 USD. With the latest stock price at 1.70 USD, the upside of Spero Therapeutics Inc based on DCF is 62.4%.
Based on the latest price of 1.70 USD and our DCF valuation, Spero Therapeutics Inc (SPRO) is a buy. buying SPRO stocks now will result in a potential gain of 62.4%.
| Range | Selected | |
| WACC / Discount Rate | 6.7% - 9.6% | 8.1% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | 2.02 - 5.59 | 2.76 |
| Upside | 18.6% - 228.6% | 62.4% |